wfukuokaya
An urologist with a passion for urologic oncology, clinical epidemiology, clinical biostatistics, and R programming.
The Jikei University School of Medicine / Tokyo Medical and Dental UniversityTokyo
Pinned Repositories
BMAs_ABI_mCSPC
Effect of BMA use on outcomes of patients with mCSPC treated with abiraterone acetate
Pem_Beyond_Prog_mUC
Association between pembrolizumab beyond radiographic progression and outcomes in patients with metastatic urotheliai carcinoma
PPI_Pem_mUC
Effect of PPI use on outcomes of pembrolizumab in metastatic urothelial carcinoma
PPIs_ABI_PCa
Individual participant-level data meta-analysis of effect of PPI use on outcomes of abiraterone acetate in patients with metastatic prostate cancer
PrognosticModel_BC
Model to predict outcomes of radical cystectomy in patients with bladder cancer
RWE_EV_mUC
Effectiveness of enfortumab vedotin for metastatic urothelial carcinoma in the real-world setting
Smoking_Pem_mUC
Dose-effect association between smoking exposure and effectiveness of pembrolizumab in patients with metastatic urothelial carcinoma
TN_subcategory
Association of a stage III substaging with outcomes of radical cystectomy in patients with bladder cancer
TrialEligibility_Pem_mUC
Effectiveness of pembrolizumab in trial-ineligible patients with metastatic urothelial carcinoma
Urethrectomy
Effect of prophylactic urethrectomy on outcomes of patients with bladder cancer undergoing radical cystectomy
wfukuokaya's Repositories
wfukuokaya/BMAs_ABI_mCSPC
Effect of BMA use on outcomes of patients with mCSPC treated with abiraterone acetate
wfukuokaya/Pem_Beyond_Prog_mUC
Association between pembrolizumab beyond radiographic progression and outcomes in patients with metastatic urotheliai carcinoma
wfukuokaya/PPI_Pem_mUC
Effect of PPI use on outcomes of pembrolizumab in metastatic urothelial carcinoma
wfukuokaya/PPIs_ABI_PCa
Individual participant-level data meta-analysis of effect of PPI use on outcomes of abiraterone acetate in patients with metastatic prostate cancer
wfukuokaya/PrognosticModel_BC
Model to predict outcomes of radical cystectomy in patients with bladder cancer
wfukuokaya/RWE_EV_mUC
Effectiveness of enfortumab vedotin for metastatic urothelial carcinoma in the real-world setting
wfukuokaya/Smoking_Pem_mUC
Dose-effect association between smoking exposure and effectiveness of pembrolizumab in patients with metastatic urothelial carcinoma
wfukuokaya/TN_subcategory
Association of a stage III substaging with outcomes of radical cystectomy in patients with bladder cancer
wfukuokaya/TrialEligibility_Pem_mUC
Effectiveness of pembrolizumab in trial-ineligible patients with metastatic urothelial carcinoma
wfukuokaya/Urethrectomy
Effect of prophylactic urethrectomy on outcomes of patients with bladder cancer undergoing radical cystectomy